Ma E, Cheng G
Infect Med (Beijing). 2023; 1(1):50-58.
PMID: 38074980
PMC: 10699679.
DOI: 10.1016/j.imj.2021.12.003.
Burton D
Nat Rev Immunol. 2023; 23(11):720-734.
PMID: 37069260
PMC: 10108814.
DOI: 10.1038/s41577-023-00858-w.
Nascimento E, Norwood B, Parker A, Braun R, Kpamegan E, Dean H
Int J Mol Sci. 2021; 22(21).
PMID: 34769432
PMC: 8584793.
DOI: 10.3390/ijms222112004.
Perspect Med Virol. 2020; 2:209-245.
PMID: 32287595
PMC: 7134342.
DOI: 10.1016/S0168-7069(08)70043-0.
Yang C, Gong R, de Val N
Virol Sin. 2019; 34(2):168-174.
PMID: 31020573
PMC: 6513807.
DOI: 10.1007/s12250-019-00093-5.
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
VanBlargan L, Goo L, Pierson T
Microbiol Mol Biol Rev. 2016; 80(4):989-1010.
PMID: 27784796
PMC: 5116878.
DOI: 10.1128/MMBR.00024-15.
VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice.
Sun M, Li Y, Yuan Z, Lu W, Kang G, Fan W
Arch Virol. 2016; 161(9):2449-55.
PMID: 27343044
PMC: 4988922.
DOI: 10.1007/s00705-016-2942-4.
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.
Klasse P
Adv Biol. 2016; 2014.
PMID: 27099867
PMC: 4835181.
DOI: 10.1155/2014/157895.
Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus.
Gao X, Hu X, Tong L, Liu D, Chang X, Wang H
BMC Vet Res. 2016; 12:39.
PMID: 26920806
PMC: 4769559.
DOI: 10.1186/s12917-016-0664-1.
A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.
Pierson T, Diamond M
Prog Mol Biol Transl Sci. 2015; 129:141-66.
PMID: 25595803
PMC: 4910618.
DOI: 10.1016/bs.pmbts.2014.10.005.
Functions of Antibodies.
Forthal D
Microbiol Spectr. 2014; 2(4):1-17.
PMID: 25215264
PMC: 4159104.
Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.
Dowd K, Mukherjee S, Kuhn R, Pierson T
J Virol. 2014; 88(20):11726-37.
PMID: 25078693
PMC: 4178732.
DOI: 10.1128/JVI.01140-14.
B cell response and mechanisms of antibody protection to West Nile virus.
Austin S, Dowd K
Viruses. 2014; 6(3):1015-36.
PMID: 24594676
PMC: 3970136.
DOI: 10.3390/v6031015.
Virus neutralisation: new insights from kinetic neutralisation curves.
Magnus C
PLoS Comput Biol. 2013; 9(2):e1002900.
PMID: 23468602
PMC: 3585397.
DOI: 10.1371/journal.pcbi.1002900.
Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.
Obara C, Dowd K, Ledgerwood J, Pierson T
Virology. 2013; 437(1):20-7.
PMID: 23312596
PMC: 3601793.
DOI: 10.1016/j.virol.2012.11.016.
A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
Dowd K, Jost C, Durbin A, Whitehead S, Pierson T
PLoS Pathog. 2011; 7(6):e1002111.
PMID: 21738473
PMC: 3128118.
DOI: 10.1371/journal.ppat.1002111.
Antibody-mediated neutralization of flaviviruses: a reductionist view.
Dowd K, Pierson T
Virology. 2011; 411(2):306-15.
PMID: 21255816
PMC: 3100196.
DOI: 10.1016/j.virol.2010.12.020.
Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.
Mehlhop E, Nelson S, Jost C, Gorlatov S, Johnson S, Fremont D
Cell Host Microbe. 2009; 6(4):381-91.
PMID: 19837377
PMC: 2782387.
DOI: 10.1016/j.chom.2009.09.003.
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.
Pierson T, Fremont D, Kuhn R, Diamond M
Cell Host Microbe. 2008; 4(3):229-38.
PMID: 18779049
PMC: 2678546.
DOI: 10.1016/j.chom.2008.08.004.
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
Pierson T, Diamond M
Expert Rev Mol Med. 2008; 10:e12.
PMID: 18471342
PMC: 2671962.
DOI: 10.1017/S1462399408000665.
